GILD · News · 20260817N

Distribution Channels

GILEAD SCIENCES, INC. · 2026-08-17 · Importance 47 · Surprise 60

The Fourth Circuit affirmed a preliminary injunction blocking entities from importing, advertising, and facilitating the importation of foreign-market Gilead medicines into the United States. The ruling specifically protects Gilead’s Biktarvy distribution channel by finding that the imported products had material differences, including labeling omissions and bypassed quality-control protocols. The court also upheld contributory-infringement findings against Meritain and ProAct, limiting access to unauthorized foreign-market versions through U.S. channels.

Key facts

• Johanna Mercier filed a Form 144 indicating intent to sell up to 28,000 shares of Gilead Sciences common stock valued at approximately $3.85 million. source
• Johanna Mercier's 28,000 shares to be sold are primarily linked to a stock option exercise and performance shares, and the filing was processed through Morgan Stanley Smith Barney LLC. source